420 related articles for article (PubMed ID: 33516215)
1. Independent association of atherogenic dyslipidaemia with all-cause mortality in individuals with type 2 diabetes and modifying effect of gender: a prospective cohort study.
Orsi E; Penno G; Solini A; Bonora E; Fondelli C; Trevisan R; Vedovato M; Cavalot F; Morano S; Baroni MG; Nicolucci A; Pugliese G;
Cardiovasc Diabetol; 2021 Jan; 20(1):28. PubMed ID: 33516215
[TBL] [Abstract][Full Text] [Related]
2. Trajectories of Blood Lipid Concentrations Over the Adult Life Course and Risk of Cardiovascular Disease and All-Cause Mortality: Observations From the Framingham Study Over 35 Years.
Duncan MS; Vasan RS; Xanthakis V
J Am Heart Assoc; 2019 Jun; 8(11):e011433. PubMed ID: 31137992
[TBL] [Abstract][Full Text] [Related]
3. Atherogenic index of plasma is associated with major adverse cardiovascular events in patients with type 2 diabetes mellitus.
Fu L; Zhou Y; Sun J; Zhu Z; Xing Z; Zhou S; Wang Y; Tai S
Cardiovasc Diabetol; 2021 Oct; 20(1):201. PubMed ID: 34610830
[TBL] [Abstract][Full Text] [Related]
4. Effect of blood lipid variability on mortality in patients with type 2 diabetes: a large single-center cohort study.
Wang MC; Li CI; Liu CS; Lin CH; Yang SY; Li TC; Lin CC
Cardiovasc Diabetol; 2021 Nov; 20(1):228. PubMed ID: 34823536
[TBL] [Abstract][Full Text] [Related]
5. Triglyceride to high-density lipoprotein cholesterol ratio and risk of atherosclerotic cardiovascular disease in a Chinese population.
Zhou L; Mai J; Li Y; Guo M; Wu Y; Gao X; Wu Y; Liu X; Zhao L
Nutr Metab Cardiovasc Dis; 2020 Sep; 30(10):1706-1713. PubMed ID: 32811737
[TBL] [Abstract][Full Text] [Related]
6. Association between lipids and apolipoproteins on type 2 diabetes risk; moderating effects of gender and polymorphisms; the ATTICA study.
Mellor DD; Georgousopoulou EN; D'Cunha NM; Naumovski N; Chrysohoou C; Tousoulis D; Pitsavos C; Panagiotakos DB;
Nutr Metab Cardiovasc Dis; 2020 May; 30(5):788-795. PubMed ID: 32127339
[TBL] [Abstract][Full Text] [Related]
7. [Diabetic dyslipidaemia and the atherosclerosis].
Márk L; Dani G
Orv Hetil; 2016 May; 157(19):746-52. PubMed ID: 27133274
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of the triglyceride to high-density lipoprotein cholesterol ratio for predicting mortality risk in type 2 diabetes: role of kidney dysfunction.
Zoppini G; Targher G; Negri C; Stoico V; Gemma ML; Bonora E
Atherosclerosis; 2010 Sep; 212(1):287-91. PubMed ID: 20510417
[TBL] [Abstract][Full Text] [Related]
9. Low-density lipoprotein cholesterol-to-apolipoprotein B ratio as a potential indicator of LDL particle size and plasma atherogenicity in type 2 diabetes.
Viktorinova A; Malickova D; Svitekova K; Choudhury S; Krizko M
Diabetes Res Clin Pract; 2021 Jun; 176():108858. PubMed ID: 34015391
[TBL] [Abstract][Full Text] [Related]
10. Triglyceride profile in dyslipidaemia of type 2 diabetes mellitus.
Khan SR; Ayub N; Nawab S; Shamsi TS
J Coll Physicians Surg Pak; 2008 May; 18(5):270-3. PubMed ID: 18541079
[TBL] [Abstract][Full Text] [Related]
11. Association of the Ratio of Triglycerides to High-Density Lipoprotein Cholesterol Levels with the Risk of Type 2 Diabetes: A Retrospective Cohort Study in Beijing.
Liu H; Yan S; Chen G; Li B; Zhao L; Wang Y; Hu X; Jia X; Dou J; Mu Y; Wen J; Lyu Z
J Diabetes Res; 2021; 2021():5524728. PubMed ID: 33969127
[TBL] [Abstract][Full Text] [Related]
12. Dose-response association between the triglycerides: High-density lipoprotein cholesterol ratio and type 2 diabetes mellitus risk: The rural Chinese cohort study and meta-analysis.
Cheng C; Liu Y; Sun X; Yin Z; Li H; Zhang M; Zhang D; Wang B; Ren Y; Zhao Y; Liu D; Zhou J; Liu X; Liu L; Chen X; Liu F; Zhou Q; Hu D
J Diabetes; 2019 Mar; 11(3):183-192. PubMed ID: 30091266
[TBL] [Abstract][Full Text] [Related]
13. Effect of alirocumab on individuals with type 2 diabetes, high triglycerides, and low high-density lipoprotein cholesterol.
Colhoun HM; Leiter LA; Müller-Wieland D; Cariou B; Ray KK; Tinahones FJ; Domenger C; Letierce A; Israel M; Samuel R; Del Prato S
Cardiovasc Diabetol; 2020 Feb; 19(1):14. PubMed ID: 32035487
[TBL] [Abstract][Full Text] [Related]
14. Alirocumab therapy in individuals with type 2 diabetes mellitus and atherosclerotic cardiovascular disease: analysis of the ODYSSEY DM-DYSLIPIDEMIA and DM-INSULIN studies.
Ray KK; Del Prato S; Müller-Wieland D; Cariou B; Colhoun HM; Tinahones FJ; Domenger C; Letierce A; Mandel J; Samuel R; Bujas-Bobanovic M; Leiter LA
Cardiovasc Diabetol; 2019 Nov; 18(1):149. PubMed ID: 31706300
[TBL] [Abstract][Full Text] [Related]
15. Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative.
Russo GT; De Cosmo S; Viazzi F; Pacilli A; Ceriello A; Genovese S; Guida P; Giorda C; Cucinotta D; Pontremoli R; Fioretto P;
Diabetes Care; 2016 Dec; 39(12):2278-2287. PubMed ID: 27703024
[TBL] [Abstract][Full Text] [Related]
16. Non-HDL cholesterol goal attainment and its relationship with triglyceride concentrations among diabetic subjects with cardiovascular disease: A nationwide survey of 2674 individuals in Hungary.
Mark L; Vallejo-Vaz AJ; Reiber I; Paragh G; Kondapally Seshasai SR; Ray KK
Atherosclerosis; 2015 Jul; 241(1):62-8. PubMed ID: 25966441
[TBL] [Abstract][Full Text] [Related]
17. Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: a clinical update.
Reiner Z
Nutr Metab Cardiovasc Dis; 2013 Sep; 23(9):799-807. PubMed ID: 23932901
[TBL] [Abstract][Full Text] [Related]
18. Triglyceride-to-high-density-lipoprotein-cholesterol ratio is an index of heart disease mortality and of incidence of type 2 diabetes mellitus in men.
Vega GL; Barlow CE; Grundy SM; Leonard D; DeFina LF
J Investig Med; 2014 Feb; 62(2):345-9. PubMed ID: 24402298
[TBL] [Abstract][Full Text] [Related]
19. Can the Plasma Concentration Ratio of Triglyceride/High-Density Lipoprotein Cholesterol Identify Individuals at High Risk of Cardiovascular Disease During 40-Year Follow-Up?
Lind L; Ingelsson E; Ärnlöv J; Sundström J; Zethelius B; Reaven GM
Metab Syndr Relat Disord; 2018 Oct; 16(8):433-439. PubMed ID: 30183521
[TBL] [Abstract][Full Text] [Related]
20. Triglyceride and HDL-C Dyslipidemia and Risks of Coronary Heart Disease and Ischemic Stroke by Glycemic Dysregulation Status: The Strong Heart Study.
Lee JS; Chang PY; Zhang Y; Kizer JR; Best LG; Howard BV
Diabetes Care; 2017 Apr; 40(4):529-537. PubMed ID: 28122840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
